Skip to content

V.H.V.: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

V.H.V.

BE 0453.249.128
NACE 86.910, Medical imaging and medical laboratories
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€22,621
2024 · €756,794-€779,416
Equity
€544,872
2024 · €567,493-€22,621
Cash
€377,300
2024 · €676,939-€299,639
Balance sheet total
€6.8m
2024 · €6.9m-€55,118

Largest movements

2024 to 2025
Assets
  • Current investments +€300,000

    new in 2025: €300,000

  • Cash -€299,639

    down €299,639 (-44.3%), from €676,939 to €377,300

    mainly Current investments (-€300,000) and Receivables within one year (-€120,244)

  • Tangible fixed assets -€180,601

    down €180,601 (-11.1%), from €1.6m to €1.4m

    of which Land and buildings: -€157,382

  • Receivables within one year +€120,244

    up €120,244 (+3.7%), from €3.3m to €3.4m

    of which Other amounts receivable: +€145,244

Equity and liabilities

No liability line moved by more than 1% of the balance sheet total.

    Income statement
    • Gross operating margin -€787,994

      down €787,994 (-82.4%), from €956,741 to €168,747

    • Other operating charges -€13,636

      down €13,636 (-66.8%), from €20,401 to €6,764

    From the 2024 result to the 2025 result

    effect on the result

    Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

    Result 2024 €756,794
    Gross operating margin -€787,994
    Depreciation -€8,116
    Other operating charges +€13,636
    Financial income +€3,834
    Financial charges +€221
    Taxes -€996
    Result 2025 -€22,621
    raises the resultlowers the result

    Derived cash bridge

    cash 2024 to 2025

    Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

    From operations +€7,886
    Investment -€307,525
    Financing €0
    Cash 2024 €676,939
    Net result for the year -€22,621
    Depreciation +€188,126
    Receivables within one year -€120,244
    Deferred charges and accrued income -€4,878
    Trade debts +€4,150
    Other debts -€36,646
    Investment in fixed assets (net) -€7,525
    Current investments -€300,000
    Cash 2025 €377,300
    brings cash intakes cash out
    Every line side by side 40 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €6,870,047 €6,814,929 -€55,118 -0.8%
    Fixed assets 21/28 €2,930,479 €2,749,878 -€180,601 -6.2%
    Tangible fixed assets 22/27 €1,626,605 €1,446,004 -€180,601 -11.1%
    Land and buildings 22 €1,523,640 €1,366,259 -€157,382 -10.3%
    Plant, machinery and equipment 23 €11,289 €9,770 -€1,519 -13.5%
    Furniture and vehicles 24 €91,676 €69,976 -€21,700 -23.7%
    Financial fixed assets 28 €1,303,874 €1,303,874 = 0.0%
    Current assets 29/58 €3,939,568 €4,065,051 +€125,483 +3.2%
    Amounts receivable within one year 40/41 €3,251,982 €3,372,226 +€120,244 +3.7%
    Trade receivables 40 €37,500 €12,500 -€25,000 -66.7%
    Other amounts receivable 41 €3,214,482 €3,359,726 +€145,244 +4.5%
    Current investments 50/53 - €300,000 +€300,000
    Cash at bank and in hand 54/58 €676,939 €377,300 -€299,639 -44.3%
    Deferred charges and accrued income 490/1 €10,647 €15,525 +€4,878 +45.8%
    Total equity and liabilities 10/49 €6,870,047 €6,814,929 -€55,118 -0.8%
    Equity 10/15 €567,493 €544,872 -€22,621 -4.0%
    Contributions 10/11 €390,000 €390,000 = 0.0%
    Reserves 13 €39,000 €39,000 = 0.0%
    Distributable reserves 133 €39,000 €39,000 = 0.0%
    Profit (loss) carried forward 14 €138,493 €115,872 -€22,621 -16.3%
    Amounts payable 17/49 €6,302,553 €6,270,057 -€32,496 -0.5%
    Amounts payable after more than one year 17 €5,800,000 €5,800,000 = 0.0%
    Financial debts 170/4 €5,800,000 €5,800,000 = 0.0%
    Amounts payable within one year 42/48 €502,553 €470,057 -€32,496 -6.5%
    Trade debts 44 €105,411 €109,560 +€4,150 +3.9%
    Suppliers 440/4 €105,411 €109,560 +€4,150 +3.9%
    Other amounts payable 47/48 €397,143 €360,497 -€36,646 -9.2%
    Non-recurring operating income 76A €792,000 - -€792,000
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €180,010 €188,126 +€8,116 +4.5%
    Other operating charges 640/8 €20,401 €6,764 -€13,636 -66.8%
    Gross operating margin 9900 €956,741 €168,747 -€787,994 -82.4%
    Operating profit (loss) 9901 €756,331 -€26,144 -€782,474
    Financial income 75/76B €6,130 €9,964 +€3,834 +62.5%
    Recurring financial income 75 €6,130 €9,964 +€3,834 +62.5%
    Financial charges 65/66B €4,488 €4,267 -€221 -4.9%
    Recurring financial charges 65 €4,488 €4,267 -€221 -4.9%
    Profit (loss) for the period before taxes 9903 €757,973 -€20,447 -€778,420
    Income taxes 67/77 €1,179 €2,175 +€996 +84.5%
    Profit (loss) for the period 9904 €756,794 -€22,621 -€779,416
    Profit (loss) for the period to be appropriated 9905 €756,794 -€22,621 -€779,416

    Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.